business
Got $2,500? 1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 20 Years
Key takeaways
- Trading at 14x forward earnings with a beta of 0.597, MDT offers defensive value as non-discretionary procedures insulate it from market downturns.
- A $185 million tariff headwind and 230-basis-point margin compression are near-term risks, but demographics and deep switching costs anchor the 20-year thesis.
- Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Medtronic didn t make the cut.
Got $2,500? 1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 20 Years Alex Sirois Sun, June 14, 2026 at 9:57 PM GMT+7 3 min read MDT NVDA Quick Read Medtronic (MDT) raised its dividend for 49 straight years while delivering $36 billion in revenue, its strongest top-line growth in 10 years.
Trading at 14x forward earnings with a beta of 0.597, MDT offers defensive value as non-discretionary procedures insulate it from market downturns.
A $185 million tariff headwind and 230-basis-point margin compression are near-term risks, but demographics and deep switching costs anchor the 20-year thesis.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop